|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of CymaBay Therapeutics (NASDAQ: CBAY) through any online brokerage.
The latest price target for CymaBay Therapeutics (NASDAQ: CBAY) was reported by JonesTrading on June 14, 2021. The analyst firm set a price target for 8.00 expecting CBAY to rise to within 12 months (a possible 72.79% upside). 7 analyst firms have reported ratings in the last year.
The stock price for CymaBay Therapeutics (NASDAQ: CBAY) is $4.63 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for CymaBay Therapeutics.
There is no upcoming split for CymaBay Therapeutics.
CymaBay Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.